There are very few studies on the pattern of neuroleptic prescription for schizophrenics in Asia. 106 schizophrenic patients in a psychiatric unit of a general teaching hospital in Hong Kong were surveyed. The mean daily dose (in chlorpromazine equivalent) was low (568.5mg). The mean daily dose of high potency agents was four times that of low potency agents. A high frequency of use of anticholinergic drugs may indicate that Chinese are more susceptible to acute extrapyramidal side-effects.
References
1.
BaldessariniRJ, DavisJM. What is the best maintenance dose of neuroleptics in schizophrenia?Psychiatry Research1980; 3: 115–122.
2.
BaldessariniRJ, KatzB, CottonP. Dissimilar dosing with high-potency and low-potency neuroleptics.American Journal of Psychiatry1984; 141: 748–752.
3.
ZitoJM, CraigTJ, WanderungJ, SiegelC. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients.American Journal of Psychiatry1987; 144: 778–782.
4.
YamamotoJ, FungD, LoS. Psychopharmacology for Asian Americans and Pacific Islanders.Pharmacology Bulletin1979; 15: 29–31.
5.
LinKM, FinderEJ. Neuroleptic dosage in Asians.American Journal of Psychiatry1983; 140: 490–491.
6.
LinKM, PolandRE, NuccioI. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.American Journal of Psychiatry1989; 146: 1307–1311.
7.
SramekJJ, SaylesMA, SimpsonGM. Neuroleptic dosage for Asians: a failure to replicate.American Journal of Psychiatry1986; 143: 4.
8.
Mental disorders: glossary and guide to their classification in accordance with the ninth revision of the International Classification of Diseases.Geneva: World Health Organization, 1978.
9.
American Psychiatric Association.Diagnostic and statistical manual of mental disorders.3rd ed.Washington DC: American Psychiatric Association, 1980.
10.
DavisJM. Comparative doses and costs of antipsychotic medication.Archives of General Psychiatry1976; 33: 858–861.
11.
OrtizA, GershonS. The future of neuroleptic psychopharmacology.Journal of Clinical Psychiatry1986; 47: 3–11.
12.
KoGN, ZhangLD, YanWW. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital.American Journal of Psychiatry1989; 146: 387–389.
13.
ChiuH, ShumPS, LamCW. Prevalence of tardive dyskinesia in Hong Kong. Presented at World Psychiatric Association Regional Symposium, Hong Kong, 1990.
14.
KaneJM, SmithJM. Tardive dyskinesia: prevalence and risk factors 1959 to 1979.Archives of General Psychiatry1982; 39: 473–481.
15.
BaldessariniRJ, CohenBM, TeicherMH. Significance of neuroleptic dose and plasma level in the pharmacolgical treatment of psychoses.Archives of General Psychiatry1988; 45: 79–91.
16.
WysowskiDK, BaumC. Antipsychotic drug use in the United States, 1976–1985.Archives of General Psychiatry1989; 46: 929–932.
17.
MichelK, KolakowskaT. A survey of prescribing psychotropic drugs in two psychiatric hospitals.British Journal of Psychiatry1981; 138: 217–221.
18.
BrayleyJ, RafalowiczE, YellowleesP. Psychotropic drug prescribing in a general hospital psychiatric unit.Australian and New Zealand Journal of Psychiatry1989; 23: 352–356.
19.
BinderRL, LevyR. Extrapyramidal reactions in Asians.American Journal of Psychiatry1981; 138: 9.
